Triple-negative breast cancer (TNBC) is a breast cancer subtype that lacks an estrogen receptor (ER), a progesterone receptor (PR), and a human epidermal growth factor receptor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.